Developer docs
API playgroundTry for free, no card

Search company profiles

Robert Wood Johnson Medical School

Full company profile

uuid0008llw

Namestring
Robert Wood Johnson Medical School
Legal namestring
Robert Wood Johnson Medical School
Company typeenum
Private
Founded yearint
1962
Descriptiontext

Robert Wood Johnson Medical School (RWJMS) is a comprehensive academic medical school and a component of Rutgers, The State University of New Jersey, operating across 17+ locations primarily in New Brunswick and Piscataway, New Jersey, with additional satellite facilities in Somerset, Monroe Township, and Edison. Founded in 1962 (originally as part of UMDNJ) and integrated into Rutgers in 2013, the school enrolls approximately 160 students per MD cohort, supports 49 graduate medical education residency and fellowship programs, offers five dual-degree tracks, and employs 2,500+ clinical and basic science faculty across 19 departments. Its academic outputs include a 96% residency match rate (2026, versus a 93.5% national average) and a median graduate debt of $180,000 (2018).

RWJMS's core technology and research portfolio spans clinical care delivery through the Rutgers Health network, translational and basic science research, and biomedical computation. Notable proprietary assets include the PRISM computational tool for tumor microbiome analysis (>90% sensitivity/specificity), the NIH-funded enCLS next-generation neurostimulation device for drug-resistant epilepsy, point-of-care ultrasound (POCUS) research showing meaningful reductions in hospital length of stay, and patents in glycosylation inhibition held by the Omar Boraie Endowed Chair. The school also operates clinical facilities including the Eric B. Chandler Health Center (a federally qualified community health center) and the SIDS Center of New Jersey, alongside the CARE-PC research hub for person-centered care.

The institution operates as a non-profit public academic entity with four revenue streams: tuition and fees from MD and dual-degree programs, competitive research grants from NIH and the National Institute on Aging, clinical care revenue through Rutgers Health, and alumni donations. Governance sits with the Rutgers Board of Governors under Chancellor Brian L. Strom, with Dean Amy P. Murtha, MD, leading the medical school. RWJMS is preparing for full LCME accreditation to merge with New Jersey Medical School into the Rutgers School of Medicine (anticipated 2027), which is positioned to become one of the largest medical schools in the U.S., alongside physical expansion through the new HELIX building in New Brunswick.

Short descriptiontext

Robert Wood Johnson Medical School is a Rutgers University academic medical school in New Jersey offering MD and residency programs, biomedical research, and clinical care across 17+ locations to 2,500+ faculty and roughly 160 students per cohort.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersNew Brunswick, United States
HQ citystring
New Brunswick
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices14 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical education, graduate medical training, clinical research, biomedical research, patient care services
Industry3 codes
1Medical Schools (MD/DO Granting)
CodeEDAHAGABPrimaryYes
2Public Research Universities with Academic Medical Centers (AMCs)
CodeEDAHAAACPrimaryNo
3Health Administration & Health Policy Schools (MHA/MPH Policy)
CodeEDAHAGALPrimaryNo
NAICS code3 codes
  • Colleges, Universities, and Professional Schools6113
  • Offices of Physicians62111
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-General Medical & Surgical Hospitals, Nec8062
Product category
Academic Medical Education
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Medical Education
TypeSubscription Recurring
Description

Tuition and fees from MD program, dual-degree programs, and continuing medical education programs.

rwjms.rutgers.edu
2Research Funding
TypeProfessional Services
Description

Competitive grants from NIH, National Institute on Aging, and other federal agencies supporting research training and projects.

rwjms.rutgers.edu
3Clinical Care Revenue
TypeProfessional Services
Description

Patient care services through Rutgers Health providing healthcare services.

rwjms.rutgers.edu
4Alumni Donations
TypeAffiliate Referral
Description

Annual fund contributions and major gifts from alumni supporting student scholarships and programs.

rwjms.rutgers.edu
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1MD Program tuition and fees
ModelSubscriptionBilling cadenceAnnual
Notes

Tuition rates not publicly disclosed on website; financial aid and scholarships available through alumni Annual Fund support.

rwjms.rutgers.edu
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Robert Wood Johnson Medical School (RWJMS) is a comprehensive academic medical school offering a four-year MD program, dual-degree programs, 49 graduate medical education residency and fellowship programs, and continuing medical education. The school delivers patient care through the Rutgers Health network across 17+ locations in New Jersey and conducts federally funded biomedical, translational, and clinical research across 19 basic science and clinical departments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 96% match rate to residency programs in 2026, exceeding national rate of 93.5%
+3 more records
Product overview1 text field

Robert Wood Johnson Medical School is an academic medical school offering a comprehensive portfolio of educational programs and healthcare services. The core offerings include a four-year MD program, 49 graduate medical education residency and fellowship programs, medical student research opportunities, and clinical trials through Rutgers Health. The school operates clinical facilities including the Eric B. Chandler Health Center (a federally qualified community health center) and the SIDS Center of New Jersey. Research centers such as CARE-PC (Center Advancing Research and Evaluation for Person-Centered Care) support population health research. Continuing medical education programs serve practicing healthcare professionals. The institution is part of Rutgers University's integration toward the future Rutgers School of Medicine (anticipated accreditation in 2027).

Product and service10 records
1MD Program
CategoryMedical Education
2Graduate Medical Education
CategoryMedical Education
Description

Residency and fellowship training programs offered across 49 graduate medical education specialties for physicians pursuing advanced clinical training.

3Dual Degree Programs
CategoryMedical Education
Description

Combined degree pathways (including MD/PhD and other dual-degree tracks) integrating medical training with research or other graduate disciplines.

4Continuing Medical Education
CategoryMedical Education
Description

Professional development and continuing education programs for practicing physicians and healthcare professionals.

5Medical Student Research Training
CategoryResearch Training
Description

Structured research opportunities for medical students, including the INSPIRE Program and the MD/PhD program, providing training in biomedical investigation.

6Rutgers Health Patient Care Services
CategoryClinical Care
Description

Clinical care services delivered to patients through the Rutgers Health network at 17+ locations across New Jersey.

7Eric B. Chandler Health Center
CategoryClinical Care
Description

Federally qualified community health center operated by RWJMS providing primary care services to underserved populations in New Brunswick, New Jersey.

8SIDS Center of New Jersey
CategoryResearch and Community Health
Description

Statewide center dedicated to research, education, bereavement support, and risk reduction related to Sudden Unexpected Infant Death, operating under a New Jersey Department of Health grant.

9Center Advancing Research and Evaluation for Person-Centered Care (CARE-PC)
CategoryResearch and Community Health
Description

Interdisciplinary research hub within Rutgers Health that mobilizes resources to enable patients to make informed health decisions and to study person-centered care delivery.

10Clinical Trials
CategoryClinical Care
Description

Clinical research studies offered to patients seeking advanced treatment options through Rutgers Health.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-09
Description

Academic collaboration for research on Pressure Enabled Drug Delivery (PEDD) platform covering applications in liver-directed therapies and uterine artery embolization. Company executives highlighted growing body of evidence supporting PEDD as differentiated approach.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-24
Description

Collaborative research partnership presenting 70 cardiovascular research abstracts at ACC.26, reflecting research across multiple hospitals and academic institutions.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-02-26
Description

Collaboration on COAST study developing neuropsychological tests for early Alzheimer's detection in Mandarin-speaking older adults, funded by National Institute on Aging.

4National Specialty Care Access Coalition (NSCAC)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-18
Description

Collaboration of more than 20 major US health systems including University Hospitals to address growing gap in access to medical specialists, particularly in rural communities and underserved urban neighborhoods.

news.uhhospitals.org
5New Jersey Healthcare Leaders
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-29
Description

Public-private partnerships driving innovation and expanding access across New Jersey, with emphasis on technology, AI, community trust, and shared accountability.

capitalanalyticsassociates.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-09-17
Description

NIH-funded study collaboration on next-generation neurostimulation device (enCLS) for epilepsy. Emory provides neuroimaging and brain activity datasets to refine and test enCLS algorithms. Principal investigator is Hai Sun at Rutgers Robert Wood Johnson Medical School.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-09-17
Description

Collaborating institution in $2.8 million NIH grant for development of next-generation neurostimulation device for drug-resistant epilepsy.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-17
Description

Strategic partner in NIH-funded research on epilepsy technology. Major health system partner integrated with Rutgers Health.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-01-13
Description

Collaborative research study revealing preliminary findings on impact of point-of-care ultrasound (POCUS) in hospital care, demonstrating significant reductions in length of stay and healthcare costs.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

SIDS Center of New Jersey operates under grant from NJ Department of Health and is based at Robert Wood Johnson Medical School and HMH Joseph M. Sanzari Children's Hospital.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

NYC-based medical school with major hospital system integration, NIH-funded research, and MD/PhD programs. Comparable in academic medicine operating model, graduate medical education breadth, and translational research portfolio.

TypeDirect peer
Description

The fellow Rutgers medical school (Newark-based) with which RWJMS is merging to form the future Rutgers School of Medicine. Same parent institution, same governance structure, same MD program and resident training footprint — the most directly comparable peer and the explicit integration partner for the 2027 LCME-accredited Rutgers School of Medicine.

TypeBroad incumbent
Description

NYC-based research medical school at a private Ivy League institution with strong NIH funding, residency programs, and clinical integration with NewYork-Presbyterian. Comparable in MD education, biomedical research output, and GME scale to a public peer of similar research caliber.

TypeRegional player
Description

Philadelphia-area private medical school with integrated hospital system, focused MD curriculum, and regional draw. Comparable to RWJMS in mid-Atlantic academic medicine footprint and MD education delivery model.

TypeBroad incumbent
Description

NYC-based research-intensive medical school with full-tuition scholarship model, large research portfolio, and clinical integration with NYU Langone. Comparable to RWJMS in MD education, residency training, and academic-clinical model, with substantially larger resources and reputational pull in the NY/NJ medical market.

TypeRegional player
Description

Pennsylvania-based community-focused medical school with a regional integrated health system (Geisinger) and emphasis on community health and rural care delivery. Comparable to RWJMS in academic-community-medicine model and population-health research mission.

TypeRegional player
Description

New Jersey-based, newer community-focused medical school with a 3-year accelerated MD pathway and integrated health system. Operates in the same NJ market as RWJMS and competes for in-state applicants, faculty, and clinical placements.

TypeBroad incumbent
Description

Ivy League, Philadelphia-based academic medical center with an MD program, large research portfolio, and AMC integration. Comparable to RWJMS in operating academic medicine, biomedical research, and clinical training, though at substantially larger scale and private versus public status.

TypeDirect peer
Description

Public research medical school with a major hospital partner (UPMC) and strong NIH-funded physician-scientist training. Comparable as a public-AMC-anchored MD program with research mission; RWJMS's new Senior Associate Dean Alison Morris previously led Pitt PACCSM, underscoring overlap.

TypeDirect peer
Description

NYC-area research medical school with MD program, MD/PhD training, and an affiliated clinical network serving diverse urban communities — comparable to RWJMS in mission, scale, and breadth of GME programs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Robert Wood Johnson Medical School

Academic Medical Educationrwjms.rutgers.edu

Robert Wood Johnson Medical School is a Rutgers University academic medical school in New Jersey offering MD and residency programs, biomedical research, and clinical care across 17+ locations to 2,500+ faculty and roughly 160 students per cohort.

What Robert Wood Johnson Medical School does

Robert Wood Johnson Medical School (RWJMS) is a comprehensive academic medical school and a component of Rutgers, The State University of New Jersey, operating across 17+ locations primarily in New Brunswick and Piscataway, New Jersey, with additional satellite facilities in Somerset, Monroe Township, and Edison. Founded in 1962 (originally as part of UMDNJ) and integrated into Rutgers in 2013, the school enrolls approximately 160 students per MD cohort, supports 49 graduate medical education residency and fellowship programs, offers five dual-degree tracks, and employs 2,500+ clinical and basic science faculty across 19 departments. Its academic outputs include a 96% residency match rate (2026, versus a 93.5% national average) and a median graduate debt of $180,000 (2018).

RWJMS's core technology and research portfolio spans clinical care delivery through the Rutgers Health network, translational and basic science research, and biomedical computation. Notable proprietary assets include the PRISM computational tool for tumor microbiome analysis (>90% sensitivity/specificity), the NIH-funded enCLS next-generation neurostimulation device for drug-resistant epilepsy, point-of-care ultrasound (POCUS) research showing meaningful reductions in hospital length of stay, and patents in glycosylation inhibition held by the Omar Boraie Endowed Chair. The school also operates clinical facilities including the Eric B. Chandler Health Center (a federally qualified community health center) and the SIDS Center of New Jersey, alongside the CARE-PC research hub for person-centered care.

The institution operates as a non-profit public academic entity with four revenue streams: tuition and fees from MD and dual-degree programs, competitive research grants from NIH and the National Institute on Aging, clinical care revenue through Rutgers Health, and alumni donations. Governance sits with the Rutgers Board of Governors under Chancellor Brian L. Strom, with Dean Amy P. Murtha, MD, leading the medical school. RWJMS is preparing for full LCME accreditation to merge with New Jersey Medical School into the Rutgers School of Medicine (anticipated 2027), which is positioned to become one of the largest medical schools in the U.S., alongside physical expansion through the new HELIX building in New Brunswick.

Robert Wood Johnson Medical School firmographics

Firmographics
Name
Robert Wood Johnson Medical School
Legal name
Robert Wood Johnson Medical School
Website
https://rwjms.rutgers.edu
Company type
Private
Founded year
1962
Operating status
Operating
Short description
Robert Wood Johnson Medical School is a Rutgers University academic medical school in New Jersey offering MD and residency programs, biomedical research, and clinical care across 17+ locations to 2,500+ faculty and roughly 160 students per cohort.
Ownership category
akta.pro rank

Robert Wood Johnson Medical School industry classification

Industry
Product category
Academic Medical Education
NAICS
Colleges, Universities, and Professional Schools (6113), Offices of Physicians (62111), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-General Medical & Surgical Hospitals, Nec (8062)
akta.pro primary industry
Medical Schools (MD/DO Granting) (EDAHAGAB)
akta.pro secondary industries
Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC), Health Administration & Health Policy Schools (MHA/MPH Policy) (EDAHAGAL)

Keywords

  • Medical education
  • Graduate medical training
  • Clinical research
  • Biomedical research
  • Patient care services

Where Robert Wood Johnson Medical School is headquartered

Location

Headquarters

HQ city
New Brunswick
HQ country
United States
HQ region
North America

Offices14 records

Markets served

Robert Wood Johnson Medical School business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Medical Education: Tuition and fees from MD program, dual-degree programs, and continuing medical education programs.
  2. Research Funding: Competitive grants from NIH, National Institute on Aging, and other federal agencies supporting research training and projects.
  3. Clinical Care Revenue: Patient care services through Rutgers Health providing healthcare services.
  4. Alumni Donations: Annual fund contributions and major gifts from alumni supporting student scholarships and programs.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualMD Program tuition and fees

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Robert Wood Johnson Medical School product offering

Product offering

Core offering

Robert Wood Johnson Medical School (RWJMS) is a comprehensive academic medical school offering a four-year MD program, dual-degree programs, 49 graduate medical education residency and fellowship programs, and continuing medical education. The school delivers patient care through the Rutgers Health network across 17+ locations in New Jersey and conducts federally funded biomedical, translational, and clinical research across 19 basic science and clinical departments.

Product overview

Robert Wood Johnson Medical School is an academic medical school offering a comprehensive portfolio of educational programs and healthcare services. The core offerings include a four-year MD program, 49 graduate medical education residency and fellowship programs, medical student research opportunities, and clinical trials through Rutgers Health. The school operates clinical facilities including the Eric B. Chandler Health Center (a federally qualified community health center) and the SIDS Center of New Jersey. Research centers such as CARE-PC (Center Advancing Research and Evaluation for Person-Centered Care) support population health research. Continuing medical education programs serve practicing healthcare professionals. The institution is part of Rutgers University's integration toward the future Rutgers School of Medicine (anticipated accreditation in 2027).

Differentiator

Problem solved

Functional benefit

Products and services

  • MD Program
  • Graduate Medical Education Residency and fellowship training programs offered across 49 graduate medical education specialties for physicians pursuing advanced clinical training.
  • Dual Degree Programs Combined degree pathways (including MD/PhD and other dual-degree tracks) integrating medical training with research or other graduate disciplines.
  • Continuing Medical Education Professional development and continuing education programs for practicing physicians and healthcare professionals.
  • Medical Student Research Training Structured research opportunities for medical students, including the INSPIRE Program and the MD/PhD program, providing training in biomedical investigation.
  • Rutgers Health Patient Care Services Clinical care services delivered to patients through the Rutgers Health network at 17+ locations across New Jersey.
  • Eric B. Chandler Health Center Federally qualified community health center operated by RWJMS providing primary care services to underserved populations in New Brunswick, New Jersey.
  • SIDS Center of New Jersey Statewide center dedicated to research, education, bereavement support, and risk reduction related to Sudden Unexpected Infant Death, operating under a New Jersey Department of Health grant.
  • Center Advancing Research and Evaluation for Person-Centered Care (CARE-PC) Interdisciplinary research hub within Rutgers Health that mobilizes resources to enable patients to make informed health decisions and to study person-centered care delivery.
  • Clinical Trials Clinical research studies offered to patients seeking advanced treatment options through Rutgers Health.

Quantifiable outcome

  • 96% match rate to residency programs in 2026, exceeding national rate of 93.5%
  • +3 more outcomes

Companies that use Robert Wood Johnson Medical School

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Robert Wood Johnson Medical School technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Robert Wood Johnson Medical School partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered minor and core.

  • TriSalus Life SciencesminorStrategic or Co-development Partner · 9 April 2026Academic collaboration for research on Pressure Enabled Drug Delivery (PEDD) platform covering applications in liver-directed therapies and uterine artery embolization. Company executives highlighted growing body of evidence supporting PEDD as differentiated approach.
  • RWJBarnabas HealthcoreStrategic or Co-development Partner · 24 March 2026Collaborative research partnership presenting 70 cardiovascular research abstracts at ACC.26, reflecting research across multiple hospitals and academic institutions.
  • Stanford UniversityminorStrategic or Co-development Partner · 26 February 2026Collaboration on COAST study developing neuropsychological tests for early Alzheimer's detection in Mandarin-speaking older adults, funded by National Institute on Aging.
  • National Specialty Care Access Coalition (NSCAC)coreStrategic or Co-development Partner · 18 February 2026Collaboration of more than 20 major US health systems including University Hospitals to address growing gap in access to medical specialists, particularly in rural communities and underserved urban neighborhoods.
  • New Jersey Healthcare LeaderscoreStrategic or Co-development Partner · 29 January 2026Public-private partnerships driving innovation and expanding access across New Jersey, with emphasis on technology, AI, community trust, and shared accountability.
  • Emory University School of MedicineminorStrategic or Co-development Partner · 17 September 2025NIH-funded study collaboration on next-generation neurostimulation device (enCLS) for epilepsy. Emory provides neuroimaging and brain activity datasets to refine and test enCLS algorithms. Principal investigator is Hai Sun at Rutgers Robert Wood Johnson Medical School.
  • Stevens Institute of TechnologyminorStrategic or Co-development Partner · 17 September 2025Collaborating institution in $2.8 million NIH grant for development of next-generation neurostimulation device for drug-resistant epilepsy.
  • RWJBarnabas HealthcoreStrategic or Co-development Partner · 17 September 2025Strategic partner in NIH-funded research on epilepsy technology. Major health system partner integrated with Rutgers Health.
  • Butterfly NetworkminorStrategic or Co-development Partner · 13 January 2025Collaborative research study revealing preliminary findings on impact of point-of-care ultrasound (POCUS) in hospital care, demonstrating significant reductions in length of stay and healthcare costs.
  • Hackensack University Medical Center (HMH Joseph M. Sanzari Children's Hospital)minorStrategic or Co-development PartnerSIDS Center of New Jersey operates under grant from NJ Department of Health and is based at Robert Wood Johnson Medical School and HMH Joseph M. Sanzari Children's Hospital.

Scale indicators12 records

Recent moves8 records

Expansion highlights5 records

Robert Wood Johnson Medical School competitors and assessment

Company assessment

Broad incumbents

  • Icahn School of Medicine at Mount Sinai: NYC-based medical school with major hospital system integration, NIH-funded research, and MD/PhD programs. Comparable in academic medicine operating model, graduate medical education breadth, and translational research portfolio.
  • Columbia University Vagelos College of Physicians and Surgeons: NYC-based research medical school at a private Ivy League institution with strong NIH funding, residency programs, and clinical integration with NewYork-Presbyterian. Comparable in MD education, biomedical research output, and GME scale to a public peer of similar research caliber.
  • NYU Grossman School of Medicine: NYC-based research-intensive medical school with full-tuition scholarship model, large research portfolio, and clinical integration with NYU Langone. Comparable to RWJMS in MD education, residency training, and academic-clinical model, with substantially larger resources and reputational pull in the NY/NJ medical market.
  • Perelman School of Medicine (University of Pennsylvania): Ivy League, Philadelphia-based academic medical center with an MD program, large research portfolio, and AMC integration. Comparable to RWJMS in operating academic medicine, biomedical research, and clinical training, though at substantially larger scale and private versus public status.

Direct peers

  • Rutgers New Jersey Medical School: The fellow Rutgers medical school (Newark-based) with which RWJMS is merging to form the future Rutgers School of Medicine. Same parent institution, same governance structure, same MD program and resident training footprint — the most directly comparable peer and the explicit integration partner for the 2027 LCME-accredited Rutgers School of Medicine.
  • University of Pittsburgh School of Medicine: Public research medical school with a major hospital partner (UPMC) and strong NIH-funded physician-scientist training. Comparable as a public-AMC-anchored MD program with research mission; RWJMS's new Senior Associate Dean Alison Morris previously led Pitt PACCSM, underscoring overlap.
  • Albert Einstein College of Medicine: NYC-area research medical school with MD program, MD/PhD training, and an affiliated clinical network serving diverse urban communities — comparable to RWJMS in mission, scale, and breadth of GME programs.

Regional players

  • Sidney Kimmel Medical College at Thomas Jefferson University: Philadelphia-area private medical school with integrated hospital system, focused MD curriculum, and regional draw. Comparable to RWJMS in mid-Atlantic academic medicine footprint and MD education delivery model.
  • Geisinger Commonwealth School of Medicine: Pennsylvania-based community-focused medical school with a regional integrated health system (Geisinger) and emphasis on community health and rural care delivery. Comparable to RWJMS in academic-community-medicine model and population-health research mission.
  • Hackensack Meridian School of Medicine: New Jersey-based, newer community-focused medical school with a 3-year accelerated MD pathway and integrated health system. Operates in the same NJ market as RWJMS and competes for in-state applicants, faculty, and clinical placements.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Robert Wood Johnson Medical School social profiles

Digital presence

Robert Wood Johnson Medical School financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Robert Wood Johnson Medical School leadership team

Management profile

Number of profiles

Profiles16 records

Robert Wood Johnson Medical School subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Robert Wood Johnson Medical School funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Robert Wood Johnson Medical School M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Robert Wood Johnson Medical School

What does Robert Wood Johnson Medical School do?

Robert Wood Johnson Medical School (RWJMS) is a comprehensive academic medical school offering a four-year MD program, dual-degree programs, 49 graduate medical education residency and fellowship programs, and continuing medical education. The school delivers patient care through the Rutgers Health network across 17+ locations in New Jersey and conducts federally funded biomedical, translational, and clinical research across 19 basic science and clinical departments.

Is Robert Wood Johnson Medical School a public or private company?

Robert Wood Johnson Medical School is a private company. It is classified as state government owned and is currently operating.

When was Robert Wood Johnson Medical School founded?

Robert Wood Johnson Medical School was founded in 1962.

Where is Robert Wood Johnson Medical School based?

Robert Wood Johnson Medical School is headquartered in New Brunswick, United States, in the North America region.

How does Robert Wood Johnson Medical School make money?

Four revenue lines are on record. Medical Education is the primary driver. The others are research Funding, clinical Care Revenue and alumni Donations.

Who are Robert Wood Johnson Medical School's main competitors?

Broad incumbents on record are Icahn School of Medicine at Mount Sinai, Columbia University Vagelos College of Physicians and Surgeons, NYU Grossman School of Medicine and Perelman School of Medicine (University of Pennsylvania). Direct peers are Rutgers New Jersey Medical School, University of Pittsburgh School of Medicine and Albert Einstein College of Medicine. Regional players are Sidney Kimmel Medical College at Thomas Jefferson University, Geisinger Commonwealth School of Medicine and Hackensack Meridian School of Medicine.

Does Robert Wood Johnson Medical School have an API?

No public API is recorded for Robert Wood Johnson Medical School.

What industry is Robert Wood Johnson Medical School in?

Robert Wood Johnson Medical School's product category is Academic Medical Education. Its primary akta.pro industry code is EDAHAGAB, Medical Schools (MD/DO Granting), with a secondary code of EDAHAAAC, Public Research Universities with Academic Medical Centers (AMCs). Its NAICS code is 6113 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Unite.AIEpic’s AI Deterioration Alerts Tied to Lower Hospital MortalityA study published in NEJM AI found that routing Epic's Deterioration Index alerts directly to hospital rapid response teams was associated with an 18% reduction in risk-adjusted odds of in-hospital death among 23,132 high-risk patients across 11 New Jersey hospitals over a two-year period. Researchers at Rutgers Robert Wood Johnson Medical School and RWJBarnabas Health attribute the mortality benefit to the operational system built around the algorithm—including automated notifications, clinician education, and standing response teams—rather than the score's standalone predictive performance. The group is now evaluating alerts based on the velocity of risk score changes rather than crossing a static threshold, and the study's lead author emphasizes that the outcome improvement came from the partnership around the algorithm, not the algorithm alone.Mirage NewsAI Tool Helps Detect Patient Decline, Cuts Hospital DeathsResearchers from RWJBarnabas Health and Rutgers Robert Wood Johnson Medical School published a study in NEJM AI showing that the Epic Deterioration Index, an AI-enabled early warning system, reduced in-hospital deaths among high-risk patients by 18 percent, from 23.1 percent to 18.6 percent, across 11 hospitals in the RWJBarnabas Health system. The study evaluated 23,132 high-risk patients and found that rapid response team activations increased from 25.3 percent to 37.5 percent following implementation, while ICU transfers did not significantly increase. The findings suggest that the tool, which continuously analyzes electronic health record data and recalculates risk scores every 15 minutes, may have implications for hospitals nationwide using Epic's widely adopted electronic health record system.HIT ConsultantRWJBarnabas Links Real-Time Epic EDI Alerts Directly to Rapid Response TeamsA multi-year study led by RWJBarnabas Health and Rutgers Robert Wood Johnson Medical School evaluated an enterprise rollout of Epic's Deterioration Index (EDI) across 11 acute care hospitals involving 23,132 patients, demonstrating an 18% reduction in risk-adjusted in-hospital mortality among high-risk patients (from 23.1% to 18.6%). The system linked real-time EHR predictive scoring to automated mobile push notifications for Rapid Response Teams, increasing RRT evaluations among high-risk patients from 25.3% to 37.5% without causing a surge in ICU transfers, proving that earlier bedside intervention can reverse patient deterioration. Published in NEJM AI, the findings provide a replicable operational blueprint for health systems seeking to convert EHR data into measurable mortality reductions.ConexiantSynthetic Echo Motion May Aid ECG Risk ModelingResearchers at Rutgers Robert Wood Johnson Medical School developed an ensemble model combining synthetic echocardiographic motion from 12-lead electrocardiograms with a foundation ECG model to classify diastolic dysfunction risk phenotypes and predict heart failure-related death risk. The model achieved area under the curve (AUC) scores of 0.86 in the development cohort of 1,012 patients and 0.85 in an external test cohort of 956 patients, while also identifying high-risk patients with a 4-year heart failure-related death rate of 8.5% compared to 3.0% for low-risk patients in the CODE-15% cohort from Brazil. The research, presented at the American Society of Echocardiography 2026 Scientific Sessions, suggests the approach could improve detection of cardiac abnormalities and optimize echocardiography use in resource-limited settings, though it remains unclear whether the model improves clinical outcomes or could replace standard echocardiographic assessment.Stock TitanTriSalus to present new PEDD data at SIR 2026TriSalus Life Sciences, an oncology company listed on Nasdaq, announced its participation in the Society of Interventional Radiology 2026 Annual Scientific Meeting in Toronto, Canada from April 11-15, 2026, where it will present new clinical and preclinical data on its Pressure Enabled Drug Delivery platform. The presentations will cover applications in liver-directed therapies and uterine artery embolization, featuring research conducted with academic partners including Tulane University and Rutgers Robert Wood Johnson Medical School. Company executives highlighted the growing body of evidence supporting PEDD as a differentiated approach to improving therapeutic delivery across multiple indications.LegacyDina Wagner Bowers Obituary Dec 28, 2025Dina Wagner Bowers, a 94-year-old resident of Flemington, New Jersey, passed away peacefully at her home on December 28, 2025. Throughout her life, she was active in her community as a bus driver for Fleming's Transportation and a clinical laboratory assistant at Hunterdon Medical Center before transforming her family farm into a bed-and-breakfast. Her body was donated to Robert Wood Johnson Medical School to support medical education.RutgersPhysicians and Staff Inspire a Movement for Compassion in Health CareRutgers Health and RWJBarnabas Health have expanded a systemwide initiative called KindOR Care, originally created by Dr. Keith P. Lewis to promote kindness in high-pressure medical environments, across multiple campuses including Robert Wood Johnson Medical School and University Hospital. The organizations are actively observing World Kindness Day with events such as staff recognition, therapy dogs, and distribution of wellness items to reinforce compassion as a core institutional value.NewsEmory joins NIH-funded study to advance seizure prevention technology for epilepsyEmory University School of Medicine has partnered in a newly awarded $2.8 million NIH grant to support development of a next-generation neurostimulation device called the Epileptic-Network Closed-loop Stimulation Device (enCLS), aimed at preventing seizures in patients with drug-resistant epilepsy. The three-year R18 grant was awarded to principal investigator Hai Sun at Rutgers Robert Wood Johnson Medical School, with contributions from Stevens Institute of Technology and RWJBarnabas Health. Emory, as a high-volume epilepsy surgery center with over 60 patients implanted with responsive neurostimulation devices, will provide neuroimaging and brain activity datasets to refine and test the enCLS algorithms.FinancialContent Business PageButterfly Network and Rutgers Robert Wood Johnson Medical School Reveal Preliminary Findings from Seminal Study on Impact of POCUS in Hospital CareButterfly Network announced preliminary findings from a study by Rutgers Robert Wood Johnson Medical School demonstrating that point-of-care ultrasound (POCUS) significantly reduced hospital length of stay and healthcare costs for patients admitted with shortness of breath. Higher-acuity patients saw the most dramatic improvement, with average length of stay dropping from 39 days to 16.7 days, while lower-acuity patients experienced up to 50% cost reduction. The findings were presented at the European Association of Cardiovascular Imaging's EchoEuro-Imaging Conference in Berlin in December 2024, with full publication expected in the first half of 2025.PR NewswireReplimune Appoints Howard L. Kaufman, M.D., FACS as Chief Medical OfficerReplimune Group Inc. announced on September 8, 2017 the appointment of Howard L. Kaufman,right) as Chief Medical Officer to support its transition to a clinical-stage biotechnology company. Dr. Kaufman brings over 25 years of oncology and immunology expertise, most recently serving as Chief of the Division of Surgical Oncology at Rutgers Robert Wood Johnson Medical School and previously as President of the Society for Immunotherapy of Cancer. The appointment is intended to advance the company's Immulytic™ oncolytic immunotherapy platform toward clinical trials, with its first product RP1 scheduled to enter clinical trials later in 2017.